Stockreport
Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 [Yahoo! Finance]
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm
Check Earnings Report
The entire transaction was direct, involving the exercise of vested stock options, immediately sold as shares. No indirect entities or trusts were involved. These 10 stocks could mint the next wave of millionaires › Saira Ramasastry, a director at Mirum Pharmaceuticals (NASDAQ:MIRM) , executed the exercise of 5,000 stock options followed by an immediate open-market sale of the resulting shares for a total transaction value of $400,000 on Dec. 22, according to a recent SEC Form 4 filing Metric Value Shares sold (direct) Transaction value Post-transaction common shares (direct) Transaction value based on SEC Form 4 weighted average purchase price ($80.00); post-transaction value is $0 as no common shares remained after the transaction. What type of transaction occurred and how was it structured? The transaction involved the exercise of 5,000 vested stock options by Saira Ramasastry, immediately followed by the sale of all resulting shares in the open market, with
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | MIRM | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
MIRM alerts
MIRM alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
MIRM alerts
High impacting Mirum Pharmaceuticals, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
MIRM
NEWS
NEWS
- Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at HC Wainwright.[MarketBeat]
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance][Yahoo! Finance]
- 3 Top Growth Stocks to Buy in the First Half of 2026 [Yahoo! Finance][Yahoo! Finance]
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)[Business Wire]
- Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at Cowen Inc.[MarketBeat]
- More
MIRM
SEC Filings
SEC Filings
- 1/16/26 - Form 4
- 1/15/26 - Form 144
- 1/12/26 - Form 8-K
- MIRM's page on the SEC website
- More